BYAKANGELICIN
UNII LE80Z850I1

Substance Identification & Data

This profile provides standardized clinical and technical data for Byakangelicin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LE80Z850I1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 482-25-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
LE80Z850I1
CAS Registry Number
482-25-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BYAKANGELICIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C17H18O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
PKRPFNXROFUNDE-LLVKDONJSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c12c(c3c(cco3)c(c1ccc(o2)=O)OC)OC[C@H](C(C)(C)O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Byakangelicin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(+)-BYAKANGELICIN
BIACANGELICIN
BJACANGELICIN
BJAKANGELICIN
BYAKANGELICIN
BYAKANGELICIN, (+)-
BYANKAGELICINE

Systematic Nomenclature

5-METHOXY-8-(2,3-DIHYDROXY-3-METHYLBUTOXY)PSORALENE
7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE, 9-((2R)-2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-
7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE, 9-(2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-, (R)-
9-((2R)-2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE